Original skin care brands AMys Skin Care have been recognised as one of the top Korean skin care suppliers in Australia, the company announced today.
The company is based in Melbourne, with offices in Sydney and Adelaide, and has a global network of more than 60 stores in more than 30 countries.
In an exclusive interview with The Drum, CEO of AMys, Tony Meehan, said the company was delighted to be recognised by the Australian Cosmetic & Wound Care Council (ACWC), which has recognised AMys as one a top supplier of topical skin care and wound care products in Australia.
“We have been working hard to ensure our products are safe, effective and affordable for the community, and we’re very pleased to be recognized by the ACWC,” he said.
Mr Meehm said AMys was proud to be Australia’s #1 seller of topical and wound products, and was excited about what was to come.
“Our products are available in a wide range of skincare formulations, from organic products to commercial formulations,” he told The Drum.
“They’re all made with plant-based ingredients and formulated with natural ingredients to help heal wounds.”
And the best part of all, we’re the only brand that’s using the world’s largest skin care platform, AMys.
“Mr Miehm said the brand’s products were also available in Australia through its Australian Beauty & Body Care network.”
The Australian Beauty and Body Care community is a great resource to help us offer the best skin care available anywhere in Australia,” he added.”
As we work towards achieving the vision of bringing skin care to all Australians, AMYS has a commitment to providing quality, high-quality products that are affordable and make a difference.
“The company’s products are sold in AMys Australia, New Zealand, New York, the US and in the United Kingdom.
The ACWC has also recognised AMy as a leader in the development of topical wound care solutions.”AMys products have been used in many wound care settings in Australia and have proven to be effective for patients,” ACWC chair Dr Jill Evans said.”
Their proven effectiveness has been recognized by more than 100,000 people worldwide.
“The award comes after AMys received a 2018 World Health Organization (WHO) Excellence in Wound Medicine Award.
Dr Evans said the recognition was “another milestone in our commitment to delivering innovative solutions that are safe and effective for the health of people, pets and the environment”.”
We look forward to continued collaborations with Australian partners and continuing to expand our product offerings to other markets, including the UK and the US,” she said.AMys was named the 2017 Innovator of the Year by the World Health Organisation for its use of a plant-derived peptide to treat skin conditions including rheumatoid arthritis and psoriasis.
The Australian Company of the year is awarded to products that meet the following criteria: they are made from a plant source; they are clinically proven to treat a specific condition or condition-related condition; they use plant-like peptides that have the potential to be applied directly to skin; and they are safe for use in the body.
The top five Australian companies included:Avedo, Amys SkinCare, Amyris, Amyli, Arbutin, Elta-Ora, and Elixa.